Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

PHXM PHAXIAM Therapeutics SA

3,10

0,00 (0,00%)

Zuletzt aktualisiert: 02:00:00

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

PHAXIAM Therapeutics (NASDAQ:PHXM)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more PHAXIAM Therapeutics Charts.

PHAXIAM Therapeutics (NASDAQ:PHXM)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more PHAXIAM Therapeutics Charts.

News PHAXIAM Therapeutics SA

Form 15F-12B - Securities registration termination of foreign private issuers [Section 12(b)]
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
Montag 11 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Mittwoch 6 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Montag 4 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Montag 4 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 21 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
Dienstag 20 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 19 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024
Donnerstag 18 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 16 November 2023 (6 Monate vor) • Edgar (US Regulatory)

PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023
Dienstag 14 November 2023 (6 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 25 Oktober 2023 (7 Monate vor) • Edgar (US Regulatory)

Weitere PHAXIAM Therapeutics SA News-Artikel

Endeavour Mining

PT Perusahaan Perkebunan... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen